
ASPI Stock Forecast & Price Target
ASPI Analyst Ratings
Bulls say
ASP Isotopes Inc has demonstrated significant revenue growth, with reported revenues of approximately $4.9 million, reflecting an annual increase of about 345.5% from the previous year's $1.1 million and a sequential rise of 308.3% from $1.2 million in the prior quarter. The company’s successful application of laser-based quantum enrichment technology to ytterbium-176 has validated its processes and indicates the potential for similar advancements in enriching uranium-235, thereby positioning ASP to capitalize on the expanding advanced nuclear fuel market. Furthermore, rising global helium demand and strategic opportunities within the LEU+ and HALEU markets suggest that ASP Isotopes could see significantly higher revenue streams, supporting a positive outlook for the company's financial trajectory.
Bears say
ASP Isotopes Inc. reported a gross margin of approximately 8.7%, significantly below the estimated 62.4% and down from both the prior year's 27.0% and the previous quarter's 47.7%, indicating serious operational inefficiencies. The company experienced a net loss of $12.1 million in Q3 2025, a deterioration compared to the net loss of $7.3 million in Q3 2024, underscoring the financial strain amidst revenue delays linked to postponed production of key isotopes. Furthermore, challenges such as diminished liquidity, increased interest rates, and ongoing volatility in global credit markets contribute to a negative financial outlook, exacerbated by management's expectations of further shipment delays for critical products like silicon-28.
This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.
ASPI Analyst Forecast & Price Prediction
Start investing in ASPI
Order type
Buy in
Order amount
Est. shares
0 shares